After preliminary human health assessment found risks from certain applications, EPA is proposing to cancel all indoor aerosol, spray, and liquid formulations of propoxur inside hospitals and other commercial or institutional facilities where children may be present and all use in food-handling establishments. After these cancellations, there would be no remaining food uses, and no tolerance levels for propoxur. Action was conducted as part of agency’s registration review program.